Company intelligence
Acclaro Medical
A leading innovator of game-changing commercial solutions in the global aesthetic, ophthalmic and surgical markets.
About Acclaro Medical
Founded in 2018 by world-class industry experts and top physicians in the nation, Acclaro Corporation is a US-based, VC-backed, fast-growing medical device company committed to innovating and developing game-changing solutions to address today’s most challenging unmet needs in the global medical aesthetic, ophthalmic and surgical markets. Acclaro Medical’s flagship product, UltraClear® is the world’s first and only cold, ablative fiber laser platform, a breakthrough painless anti-aging solution and the first ablative laser not requiring topical numbing for most treatments. Powered by the revolutionary 3DMIRACL® and 3DIntelliPulse® technologies, UltraClear® is a high-speed, all-skin-type and all-in-one platform with unparalleled energy control capabilities, offering a full range of skin rejuvenation outcomes from true painless and zero-downtime anti-aging lunchtime treatments to most advanced collagen remodeling with superior results, 15-min avg. treatment time and the utmost patient safety and comfort.
Verified activity
Signals from Acclaro Medical
4 published signals
Presence & Recognition
Acclaro Medical is taking its Cold Fiber Laser Revolution to stages and conversations across the globe in September.
Reported by Acclaro Medical
Presence & Recognition
Acclaro Medical was featured in a TIME article by Shlomo Assa on the cold fiber laser revolution in aesthetic medicine.
Reported by Acclaro Medical
People
Acclaro Medical officially welcomed Maria and AJ Amadi of Amadi Plastic Surgery to the UltraClear family.
Reported by Damian Clarke
Presence & Recognition
Acclaro Medical hosted Masters of Aesthetics in San Diego for a weekend featuring the 2910 nm fiber laser and expert Q&A panels.
Reported by Acclaro Medical